CSF2 and neoplasm: In addition, the granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-transduced vaccine (GVAX), a cell-based tumor vaccine transduced by the GM-CSF gene, can be used to block the CSF2–CSF2R signaling pathway, which inhibits TAM activation [170].